Literature DB >> 26262215

An Integrated Workflow For Secondary Use of Patient Data for Clinical Research.

Guillaume Bouzillé1, Emmanuelle Sylvestre1, Boris Campillo-Gimenez1, Eric Renault1, Thibault Ledieu1, Denis Delamarre1, Marc Cuggia1.   

Abstract

This work proposes an integrated workflow for secondary use of medical data to serve feasibility studies, and the prescreening and monitoring of research studies. All research issues are initially addressed by the Clinical Research Office through a research portal and subsequently redirected to relevant experts in the determined field of concentration. For secondary use of data, the workflow is then based on the clinical data warehouse of the hospital. A datamart with potentially eligible research candidates is constructed. Datamarts can either produce aggregated data, de-identified data, or identified data, according to the kind of study being treated. In conclusion, integrating the secondary use of data process into a general research workflow allows visibility of information technologies and improves the accessability of clinical data.

Entities:  

Mesh:

Year:  2015        PMID: 26262215

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

Review 1.  Clinical Research Informatics: Supporting the Research Study Lifecycle.

Authors:  S B Johnson
Journal:  Yearb Med Inform       Date:  2017-09-11

2.  Sacroiliac joint in sarcoidosis on computed tomography: a monocentric retrospective study (SISTER).

Authors:  Simon Cadiou; Guillaume Coiffier; Stéphane Jouneau; Patrick Jego; Aleth Perdriger; Nicolas Belhomme; Raphaël Guillin; Pascal Guggenbuhl
Journal:  Rheumatol Int       Date:  2021-10-12       Impact factor: 2.631

3.  Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.

Authors:  Nicolas Belhomme; Stéphane Jouneau; Guillaume Bouzillé; Olivier Decaux; Mathieu Lederlin; Stéphanie Guillot; Antoinette Perlat; Patrick Jégo
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.